Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma

Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.
Latest website image capture
Clouds background image

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns Medical and healthcare-related publications and documentation.
    Difference
    33%
    Check dated 2024-05-22T08:12:49.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change likely indicates an update or modification in the estimated status of a medical or healthcare-related publication or documentation.
    Difference
    0.0%
    Check dated 2024-05-08T21:19:37.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 'Active, not recruiting' to 'Completed'. This change indicates that the study titled 'Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype (SWIFT-1)' has been completed with actual results reported on May 3, 2024.
    Difference
    1%
    Check dated 2024-05-06T18:02:36.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:14:53.000Z thumbnail image

Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma

Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.